Literature DB >> 23031494

Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces.

F Causa1, R Della Moglie, E Iaccino, S Mimmi, D Marasco, P L Scognamiglio, E Battista, C Palmieri, C Cosenza, L Sanguigno, I Quinto, G Scala, P A Netti.   

Abstract

There is a growing interest in identifying biomacromolecules such as proteins and peptides to functionalize metallic surfaces through noncovalent binding. One method for functionalizing materials without fundamentally changing their inherent structure is using biorecognition moieties. Here, we proved a general route to select a biomolecule adhesive motif for surface functionalization by comprehensively screening phage displayed peptides. In particular, we selected a genetically engineered M13 bacteriophage and a linear dodecapeptide derived from its pIII domain for recognizing gold surfaces in a specific and selective manner. In the phage context, we demonstrated the adhesive motif was capable to adsorb on gold in a preferential way with a morphological and viscoelastic signature of the adsorbed layer as evidenced by QCM-D and AFM investigations. Out of the phage context, the linear dodecapeptide is reproducibly found to adhere to the gold surface, and by quantitative SPR measurements, high affinity constants (K(eq)~10(6)M(-1), binding energy ~-8 kcal/mol) were determined. We proved that the interactions occurring at gold interface were mainly hydrophobic as a consequence of high frequency of hydrophobic residues in the peptide sequence. Moreover, by CD, molecular dynamics and steered molecular dynamics, we demonstrated that the molecular flexibility only played a minor role in the peptide adsorption. Such noncovalent but specific modification of inorganic surfaces through high affinity biomolecule adsorption represents a general strategy to modulate the functionality of multipurpose metallic surfaces.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23031494     DOI: 10.1016/j.jcis.2012.08.046

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  5 in total

1.  Integration of binding peptide selection and multifunctional particles as tool-box for capture of soluble proteins in serum.

Authors:  Angela Maria Cusano; Filippo Causa; Raffaella Della Moglie; Nunzia Falco; Pasqualina Liana Scognamiglio; Anna Aliberti; Raffaele Vecchione; Edmondo Battista; Daniela Marasco; Marika Savarese; Umberto Raucci; Nadia Rega; Paolo Antonio Netti
Journal:  J R Soc Interface       Date:  2014-10-06       Impact factor: 4.118

2.  Cancer-associated CD43 glycoforms as target of immunotherapy.

Authors:  Franca Maria Tuccillo; Camillo Palmieri; Giuseppe Fiume; Annamaria de Laurentiis; Marco Schiavone; Cristina Falcone; Enrico Iaccino; Ricciarda Galandrini; Cristina Capuano; Angela Santoni; Francesco Paolo D'Armiento; Claudio Arra; Antonio Barbieri; Fabrizio Dal Piaz; David Venzon; Patrizia Bonelli; Franco Maria Buonaguro; Iris Scala; Massimo Mallardo; Ileana Quinto; Giuseppe Scala
Journal:  Mol Cancer Ther       Date:  2013-12-19       Impact factor: 6.261

3.  Facet selectivity in gold binding peptides: exploiting interfacial water structure.

Authors:  Louise B Wright; J Pablo Palafox-Hernandez; P Mark Rodger; Stefano Corni; Tiffany R Walsh
Journal:  Chem Sci       Date:  2015-06-23       Impact factor: 9.825

4.  Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes.

Authors:  Enrico Iaccino; Selena Mimmi; Vincenzo Dattilo; Fabiola Marino; Patrizio Candeloro; Antonio Di Loria; Danilo Marimpietri; Antonio Pisano; Francesco Albano; Eleonora Vecchio; Simona Ceglia; Gaetanina Golino; Antonio Lupia; Giuseppe Fiume; Ileana Quinto; Giuseppe Scala
Journal:  Mol Cancer       Date:  2017-10-13       Impact factor: 27.401

Review 5.  Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives.

Authors:  Sara La Manna; Ilaria De Benedictis; Daniela Marasco
Journal:  Front Mol Biosci       Date:  2022-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.